"Fibrinolysis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The natural enzymatic dissolution of FIBRIN.
| Descriptor ID |
D005342
|
| MeSH Number(s) |
G09.188.390.150.390
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fibrinolysis".
Below are MeSH descriptors whose meaning is more specific than "Fibrinolysis".
This graph shows the total number of publications written about "Fibrinolysis" by people in this website by year, and whether "Fibrinolysis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2014 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibrinolysis" by people in Profiles.
-
Farrell M, Marconi T, Getchell J, Green R, Cipolle M, Sixta S. The "Death Diamond": Death Beyond Trauma. Am Surg. 2019 Jul 01; 85(7):757-760.
-
Chalouhi N, Tjoumakaris S, Starke RM, Hasan D, Sidhu N, Singhal S, Hann S, Gonzalez LF, Rosenwasser R, Jabbour P. Endovascular stroke intervention in young patients with large vessel occlusions. Neurosurg Focus. 2014 Jan; 36(1):E6.
-
Welsh RC, Sauriol L, Zhang Z, Kolm P, Weintraub WS, Theroux P. Cost-effectiveness of enoxaparin compared with unfractionated heparin in ST elevation myocardial infarction patients undergoing pharmacological reperfusion: a Canadian analysis of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment - Thrombolysis in Myocardial Infarction (ExTRACT-TIMI) 25 trial. Can J Cardiol. 2009 Dec; 25(12):e399-405.
-
Erlinger TP, Conlin PR, Macko RF, Bohannon AD, Miller ER, Moore TJ, Svetkey LP, Appel LJ. The impact of angiotensin II receptor blockade and the DASH diet on markers of endogenous fibrinolysis. J Hum Hypertens. 2002 Jun; 16(6):391-7.
-
Troianos CA, Sypula RW, Lucas DM, D'Amico F, Mathie TB, Desai M, Pasqual RT, Pellegrini RV, Newfeld ML. The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting. Anesthesiology. 1999 Aug; 91(2):430-5.
-
Dav? G, Ferro D, Basili S, Iuliano L, Camastra C, Giammarresi C, Santarone S, Rocca B, Landolfi R, Ciabattoni G, Cordova C, Violi F. Increased thromboxane metabolites excretion in liver cirrhosis. Thromb Haemost. 1998 Apr; 79(4):747-51.
-
Madhani J, Movsowitz H, Kotler MN. Tissue plasminogen activator (t-PA). Ther Drug Monit. 1993 Dec; 15(6):546-51.
-
Shi Y, Nardone D, Hernandez-Martinez A, Walinsky P, Bjornsson TD, Zalewski A. Fibrinolytic activity after vessel wall injury. J Am Coll Cardiol. 1992 Feb; 19(2):441-3.
-
Zalewski A, Shi Y, Nardone D, Bravette B, Weinstock P, Fischman D, Wilson P, Goldberg S, Levin DC, Bjornsson TD. Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates. Circulation. 1991 May; 83(5):1685-91.
-
Bjornsson TD, Schneider DE, Berger H. Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels. J Pharmacol Exp Ther. 1989 Jul; 250(1):154-61.